• Image of ENFLONSIA medication Image of ENFLONSIA medication
    • ENFLONSIA

    • QTY 0.7
    • 105 MG/0.7
    • Syringe
    • Near  77382

CLESROVIMAB (KLES roe VYE mab) reduces the risk of infections caused by respiratory syncytial virus (RSV). It does not treat RSV. It is still possible to get RSV after receiving this medication, but the symptoms may be less severe or not last as long. It works by giving your body extra antibodies. These are proteins that help protect your body from infection. It is a monoclonal antibody.


ENFLONSIA Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.